Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23623)

• Formulation Name: Amikacin eq 250mg injectable
• Company: Teva Parenteral Medicines

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Amikacin	(DM5PDRB)	Bacterial infection	1A00-1C4Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Sodium citrate dihydrate	(E00369)	71474	Alkalizing agent; Buffering agent; Complexing agent; Emulsifying agent
Sodium hydroxide	(E00234)	14798	Alkalizing agent
Sodium metabisulfite	(E00444)	656671	Antimicrobial preservative; Antioxidant
Sulfuric acid	(E00045)	1118	Acidulant
Water	(E00035)	962	Solvent